drugset / Trial / NCT03497988

Intranasal Oxytocin and Food Intake in Obese Adolescents

NCT03497988 ↗

Phase 2 Withdrawn Shana McCormack, MD
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of the study is to determine the effect of intranasal OXT caloric intake and eating behaviors in otherwise healthy obese adolescents. The primary objective of this study is to determine the effects of intranasal administration of oxytocin on food intake in obese, pubertal or post-pubertal adolescents (13 to \<18 years in girls, and 15 to \<20 years in boys).

Timeline

Start
2018-09
Primary completion
2020-06
Completion
2021-06

Outcome

Outcome not reported

Stopped (Business): “Grant proposal not funded, study has been withdrawn with IRB”

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide — Intranasal

Indications